Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) has a MoatMap StockRank of 91/100 based on Quality (59/100), Value (74/100), and Momentum (46/100) factor scores. The current signal is STRONG BUY. Yixintang Pharmaceutical is a Chinese retail pharmacy chain. It is a low-margin retail business facing intense domestic competition and lacks any alignment with our macro themes.
Yixintang Pharmaceutical Group Co., Ltd. operates a large-scale retail pharmacy chain, primarily serving southwestern China with an expanding national footprint. The company is a dominant regional market leader, leveraging a dense network of retail stores to secure strong purchasing power and brand loyalty. It is characterized by its integrated supply chain and a growing focus on digital healthcare and online-to-offline (O2O) services.
| Price | $1.60 |
| Market Cap | $1.0B |
| P/E (TTM) | 23.54 |
| P/E (Forward) | 8.60 |
| Price/Book | 0.87 |
| Return on Equity | 3.7% |
| Return on Invested Capital | 6.2% |
| Debt/Equity | 33.10 |
| Gross Margin | 32.1% |
| Operating Margin | 6.3% |
| Revenue Growth | -7.0% |
| Dividend Yield | 6.3% |
| Free Cash Flow | $30M |
Yixintang Pharmaceutical Group Co., Ltd. operates in the Pharmaceutical Retailers industry, part of the Healthcare sector (China).